| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |